Event Details

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

KemPharm Inc at the RBC Capital Markets 2017 Global Healthcare

Feb 22, 2017 from 9:00 AM to 9:00 AM EST


The New York Palace Hotel